Ventricular Arrhythmias During Treatment With Alteplase (Recombinant Tissue Plasminogen Activator) in Suspected Acute Myocardial Infarction.

Heart - United Kingdom
doi 10.1136/hrt.65.1.4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

TNK Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction : Results of the TIMI 10B Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction.

BMJ
1988English

Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction: Authors' Reply

BMJ
1988English

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?

Neurology International
Neurology
2016English

Incidence and Management of Ventricular Arrhythmias After Acute Myocardial Infarction.

Heart
Cardiovascular MedicineCardiology
1969English

Massive Pulmonary Embolism During Pregnancy Successfully Treated With Recombinant Tissue Plasminogen Activator

Archives of Internal Medicine
2002English

Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2006English

Intravenous and Intrapulmonary Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Massive Pulmonary Embolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
1988English

Cardiac Arrhythmias During Myocardial Infarction

Baylor University Medical Center Proceedings
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy